| 2024-05-16 | Sale | Aerovate Therapeutics, Inc. AVTE | CHIEF EXECUTIVE OFFICER | 10,000 0.0347% | $21.58 | $215,755 | -19.88% | |
| 2024-05-01 | Sale | Aerovate Therapeutics, Inc. AVTE | CHIEF EXECUTIVE OFFICER | 11,357 0.0386% | $20.34 | $230,946 | -5.13% | |
| 2024-04-16 | Sale | Aerovate Therapeutics, Inc. AVTE | CHIEF EXECUTIVE OFFICER | 10,000 0.0375% | $24.70 | $246,971 | -13.65% | |
| 2024-04-01 | Sale | Aerovate Therapeutics, Inc. AVTE | CHIEF EXECUTIVE OFFICER | 10,000 0.035% | $30.00 | $300,033 | -32.39% | |
| 2023-11-01 | Sale | Aerovate Therapeutics, Inc. AVTE | CHIEF EXECUTIVE OFFICER | 1,092 0.0039% | $10.42 | $11,379 | +89.57% | |
| 2023-07-28 | Sale | Aerovate Therapeutics, Inc. AVTE | CHIEF EXECUTIVE OFFICER | 5,478 0.024% | $18.00 | $98,604 | +3.98% | |
| 2023-07-17 | Sale | Aerovate Therapeutics, Inc. AVTE | CHIEF EXECUTIVE OFFICER | 4,522 0.0203% | $18.11 | $81,896 | +8.53% | |
| 2023-07-03 | Sale | Aerovate Therapeutics, Inc. AVTE | CHIEF EXECUTIVE OFFICER | 10,000 0.0394% | $18.00 | $180,000 | -4.01% | |
| 2023-05-02 | Sale | Aerovate Therapeutics, Inc. AVTE | CHIEF EXECUTIVE OFFICER | 693 0.0029% | $21.15 | $14,657 | -17.35% | |
| 2023-05-01 | Sale | Aerovate Therapeutics, Inc. AVTE | CHIEF EXECUTIVE OFFICER | 15,000 0.0597% | $20.61 | $309,089 | -18.91% | |
| 2023-04-03 | Sale | Aerovate Therapeutics, Inc. AVTE | CHIEF EXECUTIVE OFFICER | 15,000 0.061% | $19.39 | $290,916 | -12.41% | |
| 2023-03-01 | Sale | Aerovate Therapeutics, Inc. AVTE | CHIEF EXECUTIVE OFFICER | 15,000 0.065% | $23.81 | $357,196 | -23.72% | |
| 2023-03-01 | Sale | Aerovate Therapeutics, Inc. AVTE | CHIEF EXECUTIVE OFFICER | 30,000 0.1299% | $23.81 | $714,393 | -23.72% | |
| 2023-03-01 | Sale | Aerovate Therapeutics, Inc. AVTE | CHIEF EXECUTIVE OFFICER | 13,950 0.0601% | $23.67 | $330,243 | -23.72% | |
| 2023-02-01 | Sale | Aerovate Therapeutics, Inc. AVTE | CHIEF EXECUTIVE OFFICER | 15,000 0.0603% | $22.68 | $340,197 | -25.87% | |
| 2023-02-01 | Sale | Aerovate Therapeutics, Inc. AVTE | CHIEF EXECUTIVE OFFICER | 30,000 0.1207% | $22.68 | $680,394 | -25.87% | |
| 2023-01-03 | Sale | Aerovate Therapeutics, Inc. AVTE | CHIEF EXECUTIVE OFFICER | 30,000 0.1228% | $27.07 | $812,152 | -36.81% | |
| 2022-12-01 | Sale | Aerovate Therapeutics, Inc. AVTE | CHIEF EXECUTIVE OFFICER | 15,000 0.0599% | $18.00 | $270,000 | -5.32% | |
| 2022-12-01 | Sale | Aerovate Therapeutics, Inc. AVTE | CHIEF EXECUTIVE OFFICER | 30,000 0.1198% | $18.00 | $540,000 | -5.32% | |
| 2022-11-01 | Sale | Aerovate Therapeutics, Inc. AVTE | CHIEF EXECUTIVE OFFICER | 1,038 0.0043% | $19.50 | $20,241 | -5.71% |